Filtros de búsqueda

Lista de obras de Paolo Gallipoli

A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid Leukemia.

artículo científico publicado en 2016

A novel mouse model identifies cooperating mutations and therapeutic targets critical for chronic myeloid leukemia progression

artículo científico publicado en 2015

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

artículo científico publicado en 2020

Assessment of physical activity in an outpatient obesity clinic in southern Italy: results from a standardized questionnaire.

artículo científico publicado en 2005

Autocrine TNF-α production supports CML stem and progenitor cell survival and enhances their proliferation

artículo científico publicado en 2013

Biosimilar epoetin in elderly patients with low-risk myelodysplastic syndromes improves anemia, quality of life, and brain function

artículo científico publicado en 2014

CML cells actively evade host immune surveillance through cytokine-mediated downregulation of MHC-II expression.

artículo científico publicado en 2016

Cohesin-dependent regulation of gene expression during differentiation is lost in cohesin-mutated myeloid malignancies

artículo científico publicado en 2019

Contrasting requirements during disease evolution identify EZH2 as a therapeutic target in AML

artículo científico publicado en 2019

Cortical blindness due to sagittal sinus thrombosis in acute lymphoblastic leukaemia

scientific article published on 05 November 2008

Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.

artículo científico publicado en 2017

Effects of the novel aurora kinase/JAK inhibitor, AT9283 and imatinib on Philadelphia positive cells in vitro

artículo científico publicado en 2012

Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase Inhibition

artículo científico publicado en 2016

Epigenetic regulators as promising therapeutic targets in acute myeloid leukemia

artículo científico publicado en 2015

Functional expression and CNS distribution of a beta-alanine-sensitive neuronal GABA transporter

artículo científico publicado el 1 de agosto de 1992

Gingival infiltration in acute monoblastic leukaemia

scientific article published on 01 November 2007

Glutaminolysis is a metabolic dependency in FLT3ITD acute myeloid leukemia unmasked by FLT3 tyrosine kinase inhibition

artículo científico publicado en 2018

Hemophagocytosis and relapsed peripheral T-cell lymphoma

scientific article published on 11 November 2008

High prevalence of heparin induced thrombocytopenia with thrombosis among patients with essential thrombocytemia carrying V617F mutation

artículo científico publicado en 2017

Hurdles Toward a Cure for CML: The CML Stem Cell

artículo científico publicado el 19 de octubre de 2011

JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.

artículo científico publicado en 2014

Laboratory and clinical risk assessment to treat myelodysplatic syndromes.

artículo científico publicado en 2016

Multiple splenic calcifications

scientific article published on 20 November 2008

Neutrophil-specific granule deficiency.

artículo científico publicado en 2013

Novel epigenetic therapies in hematological malignancies: Current status and beyond.

artículo científico publicado en 2017

Restricted access to second generation tyrosine kinase inhibitors in the UK could result in suboptimal treatment for almost half of chronic myeloid leukaemia patients: results from a West of Scotland and Lothian population study

article

SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4

artículo científico publicado en 2018

Safety and efficacy of pulsed imatinib with or without G-CSF versus continuous imatinib in chronic phase chronic myeloid leukaemia patients at 5 years follow-up

artículo científico publicado en 2013

Salvage therapy with bortezomib and dexamethasone in elderly patients with relapsed/refractory multiple myeloma.

artículo científico publicado en 2015

Targeted therapy in haematological malignancies

artículo científico publicado en 2010

Targeting primitive chronic myeloid leukemia cells by effective inhibition of a new AHI-1-BCR-ABL-JAK2 complex

artículo científico publicado en 2013

The epigenetic regulators CBP and p300 facilitate leukemogenesis and represent therapeutic targets in acute myeloid leukemia.

artículo científico publicado en 2015

The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia

scientific article published on 01 November 2009

Thrombosis and hemostatic abnormalities in hematological malignancies.

artículo científico